Derval O'Carroll
Compliance Officer at INFLARX N.V.
Net worth: - $ as of 2024-03-30
Network origin in Derval O'Carroll first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
18
| Public Company | Biotechnology | 18 |
| Public Company | Pharmaceuticals: Major | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Derval O'Carroll via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Credit Suisse Securities (USA) LLC (Broker)
 Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Investment Banks/Brokers | Analyst-Equity | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
| VITRO DIAGNOSTICS, INC. | Chemicals: Major Diversified | Corporate Officer/Principal | |
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Investment Banks/Brokers | Corporate Officer/Principal | |
| AGENUS INC. | Biotechnology | Investor Relations Contact | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Coleman Research Corp.
 Coleman Research Corp. Engineering & ConstructionIndustrial Services Part of L3Harris Technologies, Inc., Coleman Research Corp. is a private company that provides aviation and aeronautical engineering. The company is based in Orlando, FL. Coleman Research was acquired by L-3 Communications Holdings, Inc. from Thermo Electron Corp. on January 03, 2001 for $65 million. | Engineering & Construction | Corporate Officer/Principal | |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | General Counsel | |
ING Financial Markets LLC
 ING Financial Markets LLC Investment Banks/BrokersFinance ING Financial Markets LLC (ING Financial) is a FINRA-registered broker/dealer headquartered in New York City. They have additional offices in Dallas, Houston and Los Angeles. The firm is a wholly-owned subsidiary of ING Financial Holdings Corp, itself a subsidiary of ING Groep NV (AMS: INGA) in The Netherlands. ING Financial offers a broad range of investment services to corporate and financial institutions, as well as other ING businesses. Their research team places a particular emphasis on emerging markets. Key product areas offered are: corporate and government debt, credit and equity derivatives, treasury products (including Repo and CP/CD issuance), interest rate derivatives, foreign exchange, structured products and securities financing. | Investment Banks/Brokers | Analyst-Equity | |
Primus Pharmaceuticals, Inc.
 Primus Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Primus Pharmaceuticals, Inc. provides prescription metabolic products to physicians and patients throughout North America. It offers prescription drug and medical food products. Its products include Alcortin A, Novacort, Fosteum, and Limbrel. The company was founded by Michael J. Martin and is headquartered in Scottsdale, AZ. | Drugstore Chains | Chief Tech/Sci/R&D Officer | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel | |
| ZEVRA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Vanderbilt University | College/University | Undergraduate Degree | |
| University of Freiburg | College/University | Doctorate Degree Undergraduate Degree | |
Cytokine Sciences, Inc.
 Cytokine Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of CASI Pharmaceuticals, Inc., Cytokine Sciences, Inc. develops biopharmaceutical products that address the role of the blood and vessels. The private company is based in Rockville, MD. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Eastern Washington University | College/University | Undergraduate Degree | |
| Yale University | College/University | Doctorate Degree Undergraduate Degree | |
| Tulane University (Louisiana) | College/University | Undergraduate Degree | |
| Pepperdine University | College/University | Graduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
| University of St. Gallen | College/University | Masters Business Admin Graduate Degree | |
| CAMURUS AB | Pharmaceuticals: Major | Director/Board Member | |
| Universidad de Buenos Aires | College/University | Doctorate Degree | |
| VIVESTO AB | Pharmaceuticals: Generic | Director/Board Member | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | General Counsel | |
InflaRx GmbH
 InflaRx GmbH BiotechnologyHealth Technology InflaRx GmbH operates as a biotech company which develops new therapeutics in the field of inflammation. It focuses on the general area of inflammation including indications such as SIRS and SEPSIS by applying innovative therapeutics in order to prevent organ dysfunction or limit progression into organ failure. The firm's complement system is activated and produces large amounts of products including complement 5a (C5a), C3a, C4a and membrane-attack complex (MAC). The company was founded in 2007 by Niels Riedemann and Renfeng Guo and is headquartered in Jena, Germany. | Biotechnology | Chairman Founder Founder Director/Board Member Director/Board Member | |
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The private company is based in Smyrna, GA. The CEO of the company is Duane Barnes. | Financial Conglomerates | Corporate Officer/Principal | |
Cross Current Research LLC
 Cross Current Research LLC Investment ManagersFinance Founded in 2009 by Dr. Alex To, Cross Current Research LLC is an independent research firm located in Skillman, New Jersey. The firm offers comprehensive fundamental industry and company-specific research, as well as technical analysis of stocks and markets. They cover the healthcare, technology and financial services sectors. Cross Current Research offers services to institutional investors. | Investment Managers | Analyst-Equity | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | President | |
| ADVICENNE | Pharmaceuticals: Generic | Corporate Officer/Principal | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| The University of Alabama School of Medicine | College/University | Doctorate Degree | |
Sanofi AB
 Sanofi AB Medical DistributorsDistribution Services Part of Sanofi, Sanofi AB is a pharmaceutical company based in Stockholm, Sweden. The Swedish company's description states that it is an international pharmaceutical company. | Medical Distributors | Corporate Officer/Principal | |
Disarm Therapeutics, Inc.
 Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
Enzyvant, Inc.
 Enzyvant, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Enzyvant, Inc. develops biopharmaceutical products. The private company is based in Cambridge, MA. William T. Symonds has been the CEO of the company since 2022. | Pharmaceuticals: Major | Chief Executive Officer | |
| Oslo Metropolitan University | College/University | Undergraduate Degree | |
| Ullevaal School of Bioengineering | College/University | Undergraduate Degree | |
Catamaran Bio, Inc.
 Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Financial Conglomerates | Chief Executive Officer | |
| Belnor BVBA | Founder | ||
| OLINK HOLDING AB | Biotechnology | Investor Relations Contact | |
| Jane Goddall Institute Belgium | Director/Board Member |
Statistics
International
| United States | 33 |
| Sweden | 7 |
| Germany | 3 |
| Norway | 3 |
| Belgium | 3 |
Sectoral
| Health Technology | 19 |
| Consumer Services | 14 |
| Finance | 9 |
| Process Industries | 2 |
| Industrial Services | 2 |
Operational
| Director/Board Member | 72 |
| Corporate Officer/Principal | 67 |
| Independent Dir/Board Member | 26 |
| Chief Executive Officer | 21 |
| Undergraduate Degree | 19 |
Most connected contacts
| Insiders | |
|---|---|
| Nicolas Fulpius | 27 |
| John Orwin | 21 |
| Thomas Taapken | 16 |
| Richard Brudnick | 13 |
| Roy Baynes | 13 |
| Jan Medina | 11 |
| Hege Hellstrom | 11 |
| Anthony Gibney | 11 |
| Alvin Shih | 11 |
| Ron Squarer | 10 |
| Mark Kubler | 8 |
| Elizabeth Reed | 8 |
| Bill Rote | 8 |
| Andrea Loewen-Rodriguez | 8 |
| Bruce P. Burnett | 7 |
- Stock Market
- Insiders
- Derval O'Carroll
- Company connections